KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Receivables (2016 - 2025)

Idexx Laboratories has reported Change in Receivables over the past 17 years, most recently at -$13.9 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$13.9 million for Q4 2025, up 50.14% from a year ago — trailing twelve months through Dec 2025 was $68.7 million (up 143.01% YoY), and the annual figure for FY2025 was $68.7 million, up 143.01%.
  • Change in Receivables for Q4 2025 was -$13.9 million at Idexx Laboratories, down from $7.7 million in the prior quarter.
  • Over the last five years, Change in Receivables for IDXX hit a ceiling of $54.7 million in Q1 2021 and a floor of -$27.8 million in Q4 2024.
  • Median Change in Receivables over the past 5 years was $7.0 million (2022), compared with a mean of $11.3 million.
  • Biggest five-year swings in Change in Receivables: surged 505.16% in 2022 and later crashed 3953.5% in 2024.
  • Idexx Laboratories' Change in Receivables stood at -$15.9 million in 2021, then soared by 139.83% to $6.3 million in 2022, then tumbled by 110.83% to -$686000.0 in 2023, then crashed by 3953.5% to -$27.8 million in 2024, then soared by 50.14% to -$13.9 million in 2025.
  • The last three reported values for Change in Receivables were -$13.9 million (Q4 2025), $7.7 million (Q3 2025), and $29.6 million (Q2 2025) per Business Quant data.